Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Greengard

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
JAMA Network Open|March 2, 2026
Collecting Social Determinants of Health in a Children's Oncology Group Trial for High-Risk NeuroblastomaEmily Jones, Arlene Naranjo, Lena E Winestone, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Pediatric Blood & Cancer|March 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)Emily Greengard, Robin Williams, Branden Moriarity, et al.
Veterinary Medicine and Science|October 26, 2017
A phase I clinical study to evaluate safety of orally administered, genetically engineered <i>Salmonella enterica</i> serovar <i>Typhimurium</i> for canine osteosarcomaSara E Fritz, Michael S Henson, Emily Greengard, et al.
Pediatric Blood & Cancer|November 6, 2024
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPEGemma Bryan, Louise Guolla, Gabriela Inés Villanueva, et al.
Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
JAMA Network Open|March 2, 2026
Collecting Social Determinants of Health in a Children's Oncology Group Trial for High-Risk NeuroblastomaEmily Jones, Arlene Naranjo, Lena E Winestone, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Pediatric Blood & Cancer|March 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)Emily Greengard, Robin Williams, Branden Moriarity, et al.
Veterinary Medicine and Science|October 26, 2017
A phase I clinical study to evaluate safety of orally administered, genetically engineered <i>Salmonella enterica</i> serovar <i>Typhimurium</i> for canine osteosarcomaSara E Fritz, Michael S Henson, Emily Greengard, et al.
Pediatric Blood & Cancer|November 6, 2024
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPEGemma Bryan, Louise Guolla, Gabriela Inés Villanueva, et al.
Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Pageof 2